Marinova Pty Ltd is delighted to announce it has been named ‘Best Marine Biotechnology Company 2024 – APAC’ in the 9th annual International Life Sciences Awards.
The International Life Sciences Awards recognise companies that are spearheading the advancement of the global life sciences industry. Award recipients demonstrate continuity in business performance and a strong commitment to undertaking new scientific endeavours.
Marinova specialises in the research, development and production of fucoidans – highly bioactive polysaccharides found naturally in brown seaweeds. High purity fucoidan is prized for its range of beneficial health properties, and is widely utilised in market-leading nutritional, skincare and animal health formulations. It is also incorporated into innovative medical devices and used in pharmaceutical research.
Speaking of the accolade, Marinova’s CEO, Mr Paul Garrott, said, “We are honoured that Marinova’s longstanding commitment to innovative marine biotechnology has been recognised. Bioactive marine compounds are increasingly garnering the attention of researchers, formulators and consumers alike. Australia, with its extensive coastline and the third largest marine area in the world, is firmly focused on the sustainable production of high-quality marine bioproducts.” Garrott continued, “The unrivalled quality and efficacy of Maritech® organic fucoidans is based on more than two decades of research and the development of a unique proprietary extraction process. They are ingredients synonymous with quality and are sought-after by some of the worlds most trusted healthcare brands. The Maritech® portfolio represents the world’s only high purity, certified organic fucoidan with global regulatory acceptance.”
The annual International Life Sciences Awards are hosted by GHP News. Further details are available in the International Life Sciences Awards 2024 Winners Supplement.
